Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI Registry

被引:38
作者
Divakaran, Sanjay [1 ,2 ,3 ]
Singh, Avinainder [1 ,2 ,4 ]
Biery, David [1 ,2 ]
Yang, Junjie [1 ,2 ]
DeFilippis, Ersilia M. [5 ]
Collins, Bradley L. [5 ]
Ramsis, Mattheus [1 ,2 ]
Qamar, Arman [3 ]
Hainer, Jon [1 ,2 ]
Klein, Josh [1 ,2 ]
Cannon, Christopher P. [3 ]
Polk, Donna M. [3 ]
Plutzky, Jorge [3 ]
Nasir, Khurram [4 ]
Januzzi, James L. [6 ,7 ]
Di Carli, Marcelo F. [1 ,2 ,3 ]
Bhatt, Deepak L. [3 ]
Blankstein, Ron [1 ,2 ,3 ]
机构
[1] Harvard Med Sch, Cardiovasc Imaging Program, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Med Sch, Cardiovasc Imaging Program, Dept Radiol, Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Harvard Med Sch, Cardiovasc Div, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA
[5] New York Presbyterian Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA
[6] Harvard Med Sch, Div Cardiol, Massachusetts Gen Hosp, Boston, MA 02115 USA
[7] Baim Inst Clin Res, Boston, MA USA
关键词
HEART-FAILURE; CARDIOVASCULAR OUTCOMES; TYPE-2; MORTALITY; EVENTS; ADOLESCENTS; TRENDS; RISK; MEN;
D O I
10.2337/dc19-0998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE We sought to determine the prevalence of diabetes and associated cardiovascular outcomes in a contemporary cohort of young individuals presenting with their first myocardial infarction (MI) at age <= 50 years. RESEARCH DESIGN AND METHODS We retrospectively analyzed records of patients presenting with a first type 1 MI at age <= 50 years from 2000 to 2016. Diabetes was defined as a hemoglobin A(1c)>= 6.5% (48 mmol/mol) or a documented diagnosis of or treatment for diabetes. Vital status was ascertained for all patients, and cause of death was adjudicated. RESULTS Among 2,097 young patients who had a type 1 MI (mean age 44.0 +/- 5.1 years, 19.3% female, 73% white), diabetes was present in 416 (20%), of whom 172 (41%) were receiving insulin. Over a median follow-up of 11.2 years (interquartile range 7.3-14.2 years), diabetes was associated with a higher all-cause mortality (hazard ratio 2.30;P< 0.001) and cardiovascular mortality (2.68;P< 0.001). These associations persisted after adjusting for baseline covariates (all-cause mortality: 1.65;P= 0.008; cardiovascular mortality: 2.10;P= 0.004). CONCLUSIONS Diabetes was present in 20% of patients who presented with their first MI at age <= 50 years and was associated with worse long-term all-cause and cardiovascular mortality. These findings highlight the need for implementing more aggressive therapies aimed at preventing future adverse cardiovascular events in this population.
引用
收藏
页码:1843 / 1850
页数:8
相关论文
共 26 条
[11]   Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies [J].
Huxley, R ;
Barzi, F ;
Woodward, M .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7533) :73-76
[12]   Type 2 diabetes in adolescents and young adults [J].
Lascar, Nadia ;
Brown, James ;
Pattison, Helen ;
Barnett, Anthony H. ;
Bailey, Clifford J. ;
Bellary, Srikanth .
LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (01) :69-80
[13]  
Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI [10.1056/NEJMoa1603827, 10.1056/NEJMc1615712]
[14]   Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012 [J].
Mayer-Davis, Elizabeth J. ;
Lawrence, Jean M. ;
Dabelea, Dana ;
Divers, Jasmin ;
Isom, Scott ;
Dolan, Lawrence ;
Imperatore, Giuseppina ;
Linder, Barbara ;
Marcovina, Santica ;
Pettitt, David J. ;
Pihoker, Catherine ;
Saydah, Sharon ;
Wagenknecht, Lynne .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (15) :1419-1429
[15]   Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012 [J].
Menke, Andy ;
Casagrande, Sarah ;
Geiss, Linda ;
Cowie, Catherine C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (10) :1021-1029
[16]   Are We Ready to Bell The Cat?: A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes [J].
Nassif, Michael E. ;
Kosiborod, Mikhail .
CIRCULATION, 2018, 138 (01) :4-6
[17]   Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes [J].
Neal, Bruce ;
Perkovic, Vlado ;
Mahaffey, Kenneth W. ;
de Zeeuw, Dick ;
Fulcher, Greg ;
Erondu, Ngozi ;
Shaw, Wayne ;
Law, Gordon ;
Desai, Mehul ;
Matthews, David R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07) :644-657
[18]   SGLT2 inhibitors: practical considerations and recommendations for cardiologists [J].
Opingari, Erika ;
Partridge, Arun C. R. ;
Verma, Subodh ;
Bajaj, Harpreet S. .
CURRENT OPINION IN CARDIOLOGY, 2018, 33 (06) :676-682
[19]   Heart Failure with Preserved Ejection Fraction [J].
Redfield, Margaret M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) :1868-1877
[20]   Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus [J].
Rhodes, E. T. ;
Prosser, L. A. ;
Hoerger, T. J. ;
Lieu, T. ;
Ludwig, D. S. ;
Laffel, L. M. .
DIABETIC MEDICINE, 2012, 29 (04) :453-463